Latest Articles
Gesynta Pharma Doses First Patient in Phase 2 Trial of Non-Hormonal, Non-Opioid Endometriosis Treatment - Femtech Insider
Gesynta Pharma Doses First Patient in Phase 2 Trial of Non-Hormonal, Non-Opioid Endometriosis Treatment Femtech Insider
Published: April 1, 2026, 11:54 a.m.
Gesynta Pharma Doses First Patient in Phase 2 Trial of Non-Hormonal, Non-Opioid Endometriosis Treatment - femtechinsider.com
Gesynta Pharma Doses First Patient in Phase 2 Trial of Non-Hormonal, Non-Opioid Endometriosis Treatment femtechinsider.com
Published: April 1, 2026, 11:54 a.m.
Report reveals what women’s health innovators get wrong about coverage - FemTech World
Report reveals what women’s health innovators get wrong about coverage FemTech World
Published: March 31, 2026, 11 a.m.
[Angelica sinensis polysaccharide ameliorates endometriosis in rats by restoring autophagic homeostasis via inhibition of Keap1/Nrf2/HO-1-mediated oxidative stress].
To investigate whether Angelica sinensis polysaccharide (ASP) ameliorates endometriosis (EMT) by suppressing oxidative stress and restoring autophagy via the Kelch-like ECH-associated protein 1 (Keap1)/nuclear factor erythroid 2-related factor 2 (Nrf2)/heme …
Published: March 31, 2026, midnight
Hope Medicine Doses First Patient in Phase III Trial of Non-Hormonal Endometriosis Treatment - Femtech Insider
Hope Medicine Doses First Patient in Phase III Trial of Non-Hormonal Endometriosis Treatment Femtech Insider
Published: March 30, 2026, 1:56 p.m.
Endometriosis advocate Padma Lakshmi to headline Women’s HealthX - FemTech World
Endometriosis advocate Padma Lakshmi to headline Women’s HealthX FemTech World
Published: March 30, 2026, 11:06 a.m.
UK Agency ARIA Funds AI and Robotic Lab Collaboration to Discover Novel Endometriosis Therapy in Under Nine Months - Femtech Insider
UK Agency ARIA Funds AI and Robotic Lab Collaboration to Discover Novel Endometriosis Therapy in Under Nine Months Femtech Insider
Published: March 26, 2026, 2:30 p.m.
Endometriosis firm wins NIH prize - FemTech World
Endometriosis firm wins NIH prize FemTech World
Published: March 26, 2026, 2:01 p.m.
Insilico Medicine and ASKA Pharmaceutical Partner to Discover Novel Drug Targets for Endometriosis, Fibroids and Adenomyosis - Femtech Insider
Insilico Medicine and ASKA Pharmaceutical Partner to Discover Novel Drug Targets for Endometriosis, Fibroids and Adenomyosis Femtech Insider
Published: March 25, 2026, 12:34 p.m.
Endometrics Wins First Prize in NIH Endometriosis Diagnostics Challenge - Femtech Insider
Endometrics Wins First Prize in NIH Endometriosis Diagnostics Challenge Femtech Insider
Published: March 23, 2026, 12:42 p.m.
Link copied to clipboard!